| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 03/16/1994 | EP0586513A1 Acidic aralkyl triazole derivatives active as angiotensin ii antagonists |
| 03/16/1994 | EP0586479A1 Dihydroxyindanone tyrosine kinase inhibitors |
| 03/16/1994 | EP0450080B1 Composition for the treatment of progressive myopia |
| 03/16/1994 | CN1083812A Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them |
| 03/16/1994 | CN1024006C Preparation method of ethynylheteroaromatic-acids having restinoic acid-like activity |
| 03/15/1994 | US5294635 Heterocyclic compounds as aldose reductase inhibitors |
| 03/15/1994 | US5294631 Substituted benzimidazoles useful as angiotension II receptor antagonists |
| 03/15/1994 | US5294620 Hypotensive agents or compounds for cardiovascular disorders |
| 03/15/1994 | US5294607 Artificial tear film of complex phospholipid over the aqueous eye layer and an overlayer of nonpolar oil |
| 03/15/1994 | US5294604 Side effect reduction |
| 03/15/1994 | CA1327805C Pilocarpine derivatives |
| 03/15/1994 | CA1327800C Derivatives of aza-2-bicyclooctane-3-carboxylic acid, processes for their preparation and pharmaceutical compositions containing them |
| 03/09/1994 | EP0586344A1 Oxazolidene derivatives and their use as pharmaceuticals |
| 03/09/1994 | EP0585896A1 Medicament for tropical application at the eye for the treatment of increased intraocular pressure |
| 03/09/1994 | EP0585383A1 Chemical compounds |
| 03/09/1994 | EP0365662B1 Antiglaucoma compositions containing combinations of alpha-2 agonists and beta-blockers |
| 03/08/1994 | US5292745 Use of 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine derivatives as free radical scavengers |
| 03/08/1994 | US5292509 Method for the disinsertion of vitreous body by an enzyme which disrupts or degrades chondroitin sulfate proteoglycan |
| 03/08/1994 | CA1327569C Hylan preparation and method of recovery thereof from animal tissues |
| 03/08/1994 | CA1327525C Treatment of glaucoma using phosphodiesterase inhibitors |
| 03/05/1994 | CA2105530A1 Pharmaceutical composition for topical application to the eye for treating increased intraocular pressure |
| 03/04/1994 | CA2484248A1 Excitatory amino acid receptor antagonists |
| 03/03/1994 | WO1994004536A1 Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension |
| 03/03/1994 | WO1994004531A1 Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
| 03/03/1994 | WO1994004518A1 Morpholino/thiomorpholino-terminated alkylamino ethynyl alanine amino diol compounds as renin inhibitors |
| 03/03/1994 | WO1994004508A1 Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 03/03/1994 | WO1994004503A1 Pyridinyl/quinolinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 03/03/1994 | WO1994004495A1 Piperidinyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension |
| 03/03/1994 | WO1994004494A1 Tachykinin antagonists |
| 03/03/1994 | WO1994004134A1 Ophthalmological preparation |
| 03/03/1994 | CA2140640A1 Tachykinin antagonists |
| 03/03/1994 | CA2138521A1 Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension |
| 03/03/1994 | CA2138518A1 Pyridinyl/quinolinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 03/03/1994 | CA2136842A1 Morpholino/thiomorpholino-terminated alkylamino ethynyl alanine amino diol compounds as renin inhibitors |
| 03/03/1994 | CA2136838A1 Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 03/02/1994 | EP0585067A1 Use of certain sulfamoyl-substituted phenethylamine derivatives to reverse drug-induced mydriasis |
| 03/02/1994 | EP0585027A1 Use of fatty acids for treating abnormal tissue calcification |
| 03/02/1994 | CN1083074A Peptide compounds |
| 03/01/1994 | US5290798 Antihistamines, antiallergens, antiinflammatory agents |
| 03/01/1994 | US5290512 Method of disinfecting a contact lens and preserving a contact lens care solution |
| 02/28/1994 | CA2104916A1 Use of certain sulfamoyl-substituted phenethylamine derivatives to reverse drug-induced mydriasis |
| 02/24/1994 | CA2104501A1 Di- and triazinediones |
| 02/23/1994 | EP0583821A1 Atriopeptins, guanylate cyclase activators, and phosphodiesterase inhibitors as treatment for glaucoma, hydrocephalus and cerebral edema (cranial fluid volume dysfunction) |
| 02/23/1994 | EP0583367A1 Methods and compositions for inhibiting deposit formation on contact lenses |
| 02/22/1994 | US5288759 Use of certain sulfamoyl-substituted phenethylamine derivatives to reverse drug-induced mydriasis |
| 02/22/1994 | US5288751 [(Substituted) phenyalkyl]furylalkynyl-and [substituted) phenyalkyl] thienylalkynyl-N-hydroxyurea inhibitors or leukotriene biosynthesis |
| 02/22/1994 | US5288749 Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors |
| 02/22/1994 | CA2104566A1 Fatty acid treatment |
| 02/17/1994 | WO1994003437A1 Benzodiazepine derivatives |
| 02/17/1994 | WO1994003170A1 Terfenadine metabolites and their optically pure isomers for treating allergic disorders |
| 02/17/1994 | WO1994003167A1 Cataract remedy |
| 02/17/1994 | WO1994003162A1 Medicaments for the treatment or prevention of elevated intraocular pressure |
| 02/17/1994 | WO1994003059A1 Enzymatically-produced dimeric il-2 and a nerve-derived transglutaminase enzyme for its preparation |
| 02/17/1994 | CA2140009A1 Benzodiazepine derivatives |
| 02/17/1994 | CA2119873A1 Enzymatically-produced dimeric il-2 and a nerve-derived transglutaminase enyzme for its preparation |
| 02/15/1994 | US5286716 Inhibitor of the proliferation of endothelial cells |
| 02/15/1994 | CA1327004C Stabilized pharmaceutical composition and method of producing same |
| 02/09/1994 | EP0581959A1 Use of macrolide compounds for eye diseases |
| 02/09/1994 | EP0581899A1 Improved process for the preparation of 1s-(1r*, 2s*, 3r*)]-n-(4-(morpholinylsulfonyl)-l-phenylalanyl-3-(2-amino-4-thiazolyl)-n- (1-cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-l-alaninamide |
| 02/08/1994 | US5284957 Substituted 1H- or 2H-tetrazoles |
| 02/08/1994 | US5284874 Administering pantetheine |
| 02/08/1994 | US5284870 Aldose reductase inhibitor |
| 02/08/1994 | US5284859 Analgesics, Alzheimer's disease |
| 02/08/1994 | US5284843 Pharmacological treatment of ocular development |
| 02/08/1994 | CA1326853C Ethynylheteroaromatic acids having retinoic acid-like activity |
| 02/03/1994 | WO1994002447A1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 02/03/1994 | WO1994002446A1 Natural amino acid derivatives as metalloproteinase inhibitors |
| 02/03/1994 | WO1994002142A1 Substituted biphenylmethylimidazopyridines |
| 02/03/1994 | CA2139779A1 Substituted biphenylmethylimidazopyridines |
| 02/02/1994 | EP0581166A1 Benzimidazoles, process for their preparation and their use as angiotensin-II antagonists |
| 02/02/1994 | EP0580738A1 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity. |
| 02/02/1994 | EP0580594A1 New inhibitors of endothelial cell proliferation |
| 02/02/1994 | EP0442958B1 Pharmaceutical composition for ophthalmic use comprising a water soluble acid addition salt of ibopamine |
| 02/02/1994 | CN1081438A Imidazole derivatives, their method of preparation and their application in therapeutic |
| 02/01/1994 | US5283261 Administering orally or topically; inhibits denaturation of protein and development of opacity in lens of the eye |
| 02/01/1994 | US5282971 Cationic polymers having quaternary ammonium group covalently bonded to membrane surface as graft copolymers; permselectivity |
| 02/01/1994 | CA1326680C N-acyl-n-naphthoylglycines as aldose reductase inhibitors |
| 01/26/1994 | EP0580541A1 New piperidine derivatives of benzimidazole as antihistanminic and antiallergic agents |
| 01/26/1994 | EP0580074A1 Stable preparation containing azelastine hydrochloride |
| 01/26/1994 | EP0408714B1 Heterocyclic sulphonylnitromethanes, process for their preparation and pharmaceutical compositions |
| 01/26/1994 | CN1023599C Process for preparing chloroaniline derivate |
| 01/25/1994 | US5281614 Substituted 1,2,4-triazoles bearing acidic functional groups as angiotensin II antagonists |
| 01/23/1994 | CA2100927A1 Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them |
| 01/20/1994 | WO1994001456A1 Oligopeptide collagen derivatives and their use in secondary cataract prevention |
| 01/20/1994 | WO1994001124A1 METHOD OF TREATING OPHTHALMIC DISORDERS USING TGF-$g(b) |
| 01/20/1994 | WO1994001115A1 Ophthalmic topical composition containing (s)-timolol hemihydrate |
| 01/20/1994 | WO1994001096A1 Methods and products for treating presbyopia |
| 01/20/1994 | WO1993021894A3 Treatment of macular degeneration |
| 01/20/1994 | CA2139429A1 Oligopeptide derivatives and their use in secondary cataract prevention |
| 01/20/1994 | CA2138644A1 Method of treating ophthalmic disorders using tgf-.beta. |
| 01/19/1994 | EP0579155A2 Aqueous preparation of arulene sodium sulfonate |
| 01/19/1994 | EP0578818A1 Immunotherapy for recurrent hsv infections |
| 01/19/1994 | CN1080873A Application of inhibitor of plasmin aktivator in treatment of inflammation and trauma |
| 01/19/1994 | CN1080849A Pharmaceutical composition for use in glaucoma treatment |
| 01/18/1994 | US5280125 Chemical process for the preparation of 3-alkylated indole |
| 01/18/1994 | US5279836 Topical application |
| 01/12/1994 | EP0578511A1 Spirooxathiolane-quinuclidine derivative, for treating Sjoegren syndrome |
| 01/12/1994 | EP0577913A1 Pharmaceutical preparation |
| 01/12/1994 | EP0577690A1 Organosulphur compounds useful for the treatment of glaucoma |
| 01/12/1994 | EP0577682A1 Small peptidic compounds useful for the treatment of glaucoma |